Table 3

Univariable Cox regression for ADHF rehospitalisation within 1 year (N=200 patients with 144 events)

VariableHR (95% CI)Wald χ2P value
IVC diameter2.44 (1.85 to 3.23)38.91<0.001
BSA1.50 (0.89 to 2.51)2.360.13
BSA corrected IVC diameter5.58 (3.11 to 10.01)33.21<0.001
Ideal BSA (BMI 25 kg/m2) corrected IVC diameter4.50 (2.72 to 7.44)34.15<0.001
Height corrected IVC diameter4.66 (2.84 to 7.65)37.25<0.001
Days hospitalised1.05 (1.01 to 1.08)7.9<0.01
Age0.99 (0.98 to 1.00)4.030.05
Men1.23 (0.86 to 1.76)1.290.26
NYHA functional class III/IV versus I/II3.39 (2.29 to 5.01)37.34<0.001
Afib/aflutter0.99 (0.71 to 1.39)0.010.95
Ischaemic heart disease0.74 (0.52 to 1.06)2.720.10
HLD0.88 (0.60 to 1.28)0.470.50
HTN1.09 (0.78 to 1.52)0.270.60
PAD0.89 (0.37 to 2.18)0.060.80
CVA1.24 (0.72 to 2.16)0.590.44
Diabetes0.98 (0.70 to 1.36)0.020.89
CKD1.05 (0.72 to 1.51)0.050.82
COPD1.21 (0.74 to 1.96)0.580.45
Delta weight0.99 (0.98 to 1.01)1.690.19
Systolic BP1.00 (0.99 to 1.00)0.700.40
Diastolic BP1.00 (0.99 to 1.01)0.090.77
HR1.01 (1.00 to 1.02)5.940.02
Creatinine1.20 (1.00 to 1.45)3.830.05
eGFR1.00 (0.99 to 1.01)0.010.91
Sodium0.95 (0.90 to 0.99)6.040.01
Potassium0.96 (0.70 to 1.32)0.070.80
Haemoglobin0.90 (0.84 to 0.96)8.88<0.01
Log NT-proBNP1.63 (1.15 to 2.32)7.35<0.01
Elevated JVP0.93 (0.66 to 1.30)0.190.66
Crackles1.03 (0.75 to 1.43)0.040.85
Peripheral oedema0.96 (0.64 to 1.45)0.040.85
LVEF0.99 (0.98 to 1.00)4.930.03
PA pressure1.02 (1.01 to 1.03)9.20<0.01
Tricuspid regurgitation1.96 (1.29 to 2.98)9.84<0.01
Mitral regurgitation1.49 (1.03 to 2.15)4.570.03
RV dysfunction1.47 (1.05 to 2.04)5.090.02
  • ADHF, acute decompensated heart failure; BMI, body mass index; BP, blood pressure; BSA, body surface area; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; eGFR, estimated glomerular filtration rate; HLD, hyperlipidaemia; HR, heart rate; HTN, hypertension; IVC, inferior vena cava; JVP, jugular venous pulse; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal B-type natriuretic peptide; NYHA, New York Heart Association; PA, pulmonary arterial; PAD, peripheral arterial disease; RV, right ventricular.